» Articles » PMID: 26493844

Emerging Bacterial Pathogens: the Past and Beyond

Overview
Publisher Elsevier
Date 2015 Oct 24
PMID 26493844
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Since the 1950s, medical communities have been facing with emerging and reemerging infectious diseases, and emerging pathogens are now considered to be a major microbiologic public health threat. In this review, we focus on bacterial emerging diseases and explore factors involved in their emergence as well as future challenges. We identified 26 major emerging and reemerging infectious diseases of bacterial origin; most of them originated either from an animal and are considered to be zoonoses or from water sources. Major contributing factors in the emergence of these bacterial infections are: (1) development of new diagnostic tools, such as improvements in culture methods, development of molecular techniques and implementation of mass spectrometry in microbiology; (2) increase in human exposure to bacterial pathogens as a result of sociodemographic and environmental changes; and (3) emergence of more virulent bacterial strains and opportunistic infections, especially affecting immunocompromised populations. A precise definition of their implications in human disease is challenging and requires the comprehensive integration of microbiological, clinical and epidemiologic aspects as well as the use of experimental models. It is now urgent to allocate financial resources to gather international data to provide a better understanding of the clinical relevance of these waterborne and zoonotic emerging diseases.

Citing Articles

Comparative antibacterial activity of clove extract against Pseudomonas aeruginosa.

Al-Tawalbeh D, Alawneh J, Momani W, Mayyas A BMC Complement Med Ther. 2025; 25(1):7.

PMID: 39789583 PMC: 11716342. DOI: 10.1186/s12906-024-04740-7.


New Benzofuran-Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies.

Abd El-Karim S, Anwar M, Syam Y, Awad H, El-Dein A, El-Ashrey M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770506 PMC: 11676098. DOI: 10.3390/ph17121664.


Large-scale genomic analysis of Elizabethkingia anophelis.

Andriyanov P, Zhurilov P, Menshikova A, Tutrina A, Yashin I, Kashina D BMC Genomics. 2024; 25(1):1015.

PMID: 39472795 PMC: 11523902. DOI: 10.1186/s12864-024-10921-y.


Biosensing technology for detection and assessment of pathogenic microorganisms.

Sinha S, Bachan Upadhyay L Future Microbiol. 2024; 20(1):57-72.

PMID: 39469851 PMC: 11731313. DOI: 10.1080/17460913.2024.2417621.


Highly sensitive label-free biomolecular detection using Au-WS nanohybrid based SERS substrates.

Prakash O, T A, Nagpal P, Perumal V, Karak S, Singh U Nanoscale Adv. 2024; .

PMID: 39372440 PMC: 11447697. DOI: 10.1039/d4na00464g.


References
1.
Funke G, von Graevenitz A, Clarridge 3rd J, Bernard K . Clinical microbiology of coryneform bacteria. Clin Microbiol Rev. 1997; 10(1):125-59. PMC: 172946. DOI: 10.1128/CMR.10.1.125. View

2.
McDade J, SHEPARD C, Fraser D, Tsai T, Redus M, Dowdle W . Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med. 1977; 297(22):1197-203. DOI: 10.1056/NEJM197712012972202. View

3.
Hahn D, Schure A, Patel K, Childs T, Drizik E, Webley W . Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS One. 2012; 7(4):e35945. PMC: 3335830. DOI: 10.1371/journal.pone.0035945. View

4.
Welinder-Olsson C, Kjellin E, Vaht K, Jacobsson S, Wenneras C . First case of human "Candidatus Neoehrlichia mikurensis" infection in a febrile patient with chronic lymphocytic leukemia. J Clin Microbiol. 2010; 48(5):1956-9. PMC: 2863919. DOI: 10.1128/JCM.02423-09. View

5.
Goodman J, Nelson C, Vitale B, Madigan J, Dumler J, Kurtti T . Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med. 1996; 334(4):209-15. DOI: 10.1056/NEJM199601253340401. View